期刊文献+

白介素-17、白介素-33与支气管哮喘关系的研究进展 被引量:3

Research progress on relationship between interleukin-17, interleukin-33 and bronchial asthma
下载PDF
导出
摘要 为研究白介素-17及白介素-33与支气管哮喘的关系,本文将各学者的研究成果与本人的临床经验结合,对相关问题进行了总结。首先,本文分析了支气管哮喘及其病因,介绍了白细胞介素,阐述了白细胞介素的功能。其次,分析了白介素-17及白介素-33与支气管哮喘发病之间的关系,强调了通过调整白介素-17及白介素-33治疗支气管哮喘的重要性。最后从中西医两方面出发,观察了采用不同方法治疗支气管哮喘,对白介素-17及白介素-33指标的影响。最终证实了白介素-17及白介素-33在疾病诊断、病情评估中的应用价值。 In order to study the relationship between interleukin-17,interleukin-33 and bronchial asthma,this paper summarizes the related problems by combining the research results of various scholars with my own clinical experience. Firstly,this paper analyzes bronchial asthma and its etiology,introduces interleukin,and expounds the function of interleukin. Secondly,the relationship between interleukin-17 and interleukin-33 and asthma was analyzed,and the importance of adjusting interleukin-17 and interleukin-33 in the treatment of bronchial asthma were emphasized. Finally,from the two aspects of traditional Chinese and western medicine,the different methods of treating bronchial asthma were observed. The effects of interleukin-17 and interleukin-33 on bronchial asthma were studied. Finally,the value of interleukin-17 and interleukin-33 in the diagnosis and evaluation of disease was confirmed.
作者 徐青 XU Qing(Department of Respiratory Medicine,Affiliated Hospital of Guilin Medical College,Guangxi Zhuang Autonomous Region,Guilin 541001,China)
出处 《中国当代医药》 2019年第14期35-37,共3页 China Modern Medicine
基金 广西壮族自治区医疗卫生适宜技术开发与推广应用项目(S201604)
关键词 白介素-17 白介素-33 支气管哮喘 发病原因 Interleukin-17 Interleukin-33 Bronchial asthma Pathogenesis
  • 相关文献

参考文献20

二级参考文献150

  • 1杨慧,向平超.支气管哮喘全球倡议(2012更新版)简介[J].中国医学前沿杂志(电子版),2013,5(8):25-29. 被引量:22
  • 2印根权,赵顺英,江载芳.哮喘候选基因的研究进展[J].中国循证儿科杂志,2007,2(1):43-54. 被引量:5
  • 3Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma[J]. Front Microbiol, 2013, 4: 263.
  • 4Lambrecht BN, Hammad H. Asthma: the importance of dysregulated barrier immunity[J]. Eur J Immunol, 2013, 43(12): 3125-3137.
  • 5Ma L, Xue HB, Guan XH, et al. Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis[J]. Clin Exp Immunol, 2014, 175(1): 25-31.
  • 6Kerzerho J, Maazi H, Speak AO, et al. Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity[J]. J Allergy Clin Immunol, 2013, 131(4): 1048-1057.
  • 7Jutel M, Akdis CA. T-cell subset regulation in atopy[J]. Curr Allergy Asthma Rep, 2011, 11(2): 139-145.
  • 8Xing J, Wu Y, Ni B. Th9: a new player in asthma pathogenesis?[J]. J Asthma, 2011, 48(2): 115-125.
  • 9Soroosh P, Doherty TA. Th9 and allergic disease [J]. Immunology, 2009, 127(4): 450-458.
  • 10Morishima Y, Ano S, Ishii Y, et ah Thl7-associated cytokines as a therapeutic target for steroid-insensitive asthma[J]. Clin Dev Immunol, 2013, 2013: 609395.

共引文献221

同被引文献33

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部